z-logo
open-access-imgOpen Access
Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment
Author(s) -
Catalina Ayón,
Daniel Castán,
Adrián Mora,
Dunia Naranjo,
Francini Obando,
Juan José Mora
Publication year - 2022
Publication title -
borneo journal of pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2621-4814
DOI - 10.33084/bjop.v5i3.2095
Subject(s) - medicine , infliximab , certolizumab pegol , posterior segment of eyeball , ranibizumab , bevacizumab , adalimumab , diabetic retinopathy , adverse effect , ophthalmology , uveitis , monoclonal antibody , endophthalmitis , macular degeneration , monoclonal , dermatology , rheumatoid arthritis , surgery , pathology , antibody , immunology , disease , pharmacology , chemotherapy , diabetes mellitus , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here